摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

acetyloxy[[(1,1-dimethylethoxy)carbonyl]amino]acetic acid methyl ester | 173306-81-5

中文名称
——
中文别名
——
英文名称
acetyloxy[[(1,1-dimethylethoxy)carbonyl]amino]acetic acid methyl ester
英文别名
N-tert-butyloxycarbonyl-α-acetoxyglycine methyl ester;methyl 2-acetoxy-2-(tert-butoxycarbonylamino)acetate;methyl N-Boc-2-acetoxyglycine;methyl 2-acetoxy-2-[((1,1-dimethylethoxy)carbonyl)amino]acetate;methyl 2-acetyloxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate
acetyloxy[[(1,1-dimethylethoxy)carbonyl]amino]acetic acid methyl ester化学式
CAS
173306-81-5
化学式
C10H17NO6
mdl
——
分子量
247.248
InChiKey
NVLYIFJPIVHPGY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    342.0±32.0 °C(Predicted)
  • 密度:
    1.159±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    17
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    90.9
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    acetyloxy[[(1,1-dimethylethoxy)carbonyl]amino]acetic acid methyl ester 在 phosphate buffer 、 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 20.0h, 生成 Boc-L-炔丙基甘氨酸
    参考文献:
    名称:
    Zinc mediated addition of active halides to a glycine cation equivalent: Synthesis of N-Boc-L-propargylglycine
    摘要:
    The reaction of allylic, benzylic and propargylic halides with zinc in the presence of the glycine cation equivalent, methyl N-Boc-2-acetoxyglycine, affords Boc protected amino acid derivatives in high yield. Resolution of methyl N-Boc-propargylglycine with alpha-chymotrypsin affords N-Boc-L-propargylglycine in 99% e.e..
    DOI:
    10.1016/s0040-4039(00)73067-x
  • 作为产物:
    参考文献:
    名称:
    Zinc mediated addition of active halides to a glycine cation equivalent: Synthesis of N-Boc-L-propargylglycine
    摘要:
    The reaction of allylic, benzylic and propargylic halides with zinc in the presence of the glycine cation equivalent, methyl N-Boc-2-acetoxyglycine, affords Boc protected amino acid derivatives in high yield. Resolution of methyl N-Boc-propargylglycine with alpha-chymotrypsin affords N-Boc-L-propargylglycine in 99% e.e..
    DOI:
    10.1016/s0040-4039(00)73067-x
点击查看最新优质反应信息

文献信息

  • Synthesis of a Naturally Occurring Diene-Containing Amino Acid and Its Glutamyl Dipeptide viaN-Acyliminium Ion Chemistry
    作者:Martin Berkheij、Jan Dijkink、Olivier R. P. David、Theo Sonke、Denis R. IJzendoorn、Richard H. Blaauw、Jan H. van Maarseveen、Hans E. Schoemaker、Henk Hiemstra
    DOI:10.1002/ejoc.200701016
    日期:2008.2
    The syntheses of the naturally occurring unusual unsaturated amino acid (S)-2-amino-3-methylene-4-pentenoic acid and the corresponding gamma-glutamyl dipeptide are described. Key steps are an N-acyliminium ion addition using allenyhnethylsilane as nucleophile and an enzymatic resolution mediated by the L-aminopeptidase from Pseudomonas putida.
    描述了天然存在的罕见不饱和氨基酸 (S)-2-amino-3-methylene-4-pentenoic 酸和相应的 γ-谷氨酰二肽的合成。关键步骤是使用丙二烯基乙基硅烷作为亲核试剂的 N-acyliminium 离子加成和由来自恶臭假单胞菌的 L-氨基肽酶介导的酶促拆分。
  • Hetero-substituted metalloprotease inhibitors
    申请人:The Procter & Gamble Company
    公开号:US06566381B1
    公开(公告)日:2003-05-20
    Heterocyclic substituted compounds having the general structure: which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes.
    具有一般结构的杂环取代化合物:这些化合物是金属蛋白酶抑制剂,对于治疗由这些酶活性过高所表征的疾病有效。
  • Expedient Pyrrolizidine Synthesis by Propargylsilane Addition to<i>N</i>-Acyliminium Ions followed by Gold-Catalyzed α-Allenyl Amide Cyclization
    作者:Arjen C. Breman、Jan Dijkink、Jan H. van Maarseveen、Sape S. Kinderman、Henk Hiemstra
    DOI:10.1021/jo901393y
    日期:2009.8.21
    A reaction sequence, involving the addition of (substituted) propargylsilanes to lactam-derived N-acyliminium ions followed by gold-catalyzed cyclization of the resulting α-allenyl amide, is applied in expedient syntheses of pyrrolizidine alkaloids heliotridine and ent-retronecine in five steps from (S)-malic acid.
    在五个步骤中,将反应顺序(包括将(取代的)炔丙基硅烷添加到内酰胺衍生的N-酰基亚胺离子中,然后用金催化的环化所得的α-烯丙基酰胺)进行吡咯烷核生物碱类四氢吡啶和对-维甲酸的合成来自(S)-苹果酸。
  • Synthesis of N-protected-.alpha.-substituted-glycine racemic esters by
    申请人:G.D. Searle & Co.
    公开号:US05508466A1
    公开(公告)日:1996-04-16
    A method is described for synthesis of N-Boc-L-propargylglycine, a key intermediate used in the preparation of high-potency, orally-active renin inhibitors. This method involves reaction of an organic halide with a glycine cation equivalent, such as methyl N-Boc-2-acetoxyglycine, in the presence of zinc dust to give Boc-protected amino acid derivatives in high yield. Typically useful organic halides are allylic, benzylic and propargylic halides. Resolution of methyl N-Boc-propargylglycine with .alpha.-chymotrypsin provides N-Boc-L-propargylglycine in high yield.
    本文描述了一种合成N-Boc-L-丙炔基甘氨酸的方法,这是制备高效、口服活性肾素抑制剂的关键中间体。该方法涉及有机卤化物与甘氨酸阳离子当量(例如甲基N-Boc-2-乙酰氧基甘氨酸)在锌粉存在下反应,高产率地得到Boc保护的氨基酸衍生物。通常有用的有机卤化物是烯丙基、苄基和丙炔基卤化物。用.alpha.-胰蛋白酶分离甲基N-Boc-丙炔基甘氨酸可以高产率地得到N-Boc-L-丙炔基甘氨酸。
  • Dihetero-substituted metalloprotease inhibitors
    申请人:The Procter & Gamble Company
    公开号:US20030225074A1
    公开(公告)日:2003-12-04
    Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have a structure according to the following Formula (I): 1 where J, M, Q, T, W, X, Z, R 1 , R 2 , R 3 , R 4 , R 4′ , R 5 , R 6 , R 6′ , R 7 , m, and n have the meanings described in the specification. This invention also includes optical isomers, diastereomers and enantiomers of the formula above, and pharmaceutically-acceptable salts, biohydrolyzable amides, esters, and imides thereof. Also disclosed are pharmaceutical compositions comprising these compounds, and methods of treating or preventing metalloprotease-related maladies using the compounds or the pharmaceutical compositions.
    本发明涉及一种金属蛋白酶抑制剂化合物,用于治疗由这些酶的过度活性引起的疾病。特别地,该化合物具有以下式(I)的结构:其中J、M、Q、T、W、X、Z、R1、R2、R3、R4、R4'、R5、R6、R6'、R7、m和n在规范中有所描述。本发明还包括该式的光学异构体、对映异构体和对映体,以及其药物可接受的盐、生物可水解的酰胺、酯和亚酰酰胺。还公开了包含这些化合物的药物组合物,以及使用该化合物或药物组合物治疗或预防金属蛋白酶相关疾病的方法。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物